Here’s some interesting news from The Scripps Research Institute (TSRI) and the Mayo Clinic. Researchers found that a combination of two drugs — cancer drug dasatinib and quercetin — “dramatically slows the aging process (in animal models)—alleviating symptoms of frailty, improving cardiac function and extending a healthy lifespan.” The Independent reports on it here.
New Class of Drugs Could Dramatically Increase Healthy Lifespan